Daily Brief Health Care: Olympus Corp, Leatt Corporation, SofWave Medical and more

• Olympus Corp (7733 JP) shares retreated 17% over the last one month, dragged by resignation of the CEO and weak H1FY25 result. No definite time for CEO succession is announced.
• Favorable Fx inflated H1FY25 result. On a Fx neutral basis, revenue growth is only 3% YoY, while adjusted operating profit growth is just 4% YoY.
• Olympus has guided for 9% YoY revenue growth to ¥1,009B in FY25, indicating H2FY25 revenue of ¥535B (-9% YoY). ESD revenue guidance seems to be aggressive amid current macro backdrop.

• Leatt Corporation is currently trading at a significant discount to its intrinsic value, making it an appealing opportunity for investors
• The company has a solid balance sheet, historical growth trends, and potential for margin improvement, further enhancing its investment appeal
• With a focus on organic growth and target operating margins, Leatt Corporation is well-positioned for success in the personal protection equipment industry for mountain bikes and motorbikes

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

• Led by experienced entrepreneur in energy-based aesthetic device industry
• Focus on high gross profit margin through razor-and-blade business model
• Plans for potential take-private transaction and NASDAQ listing for increased visibility and profitability

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.